Impact of Thoracoscopic Pulmonary Vein Isolation on Right Ventricular Function: A Pilot Study by De Maat, Gijs E et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Impact of Thoracoscopic Pulmonary Vein Isolation on Right Ventricular
Function: A Pilot Study
De Maat, Gijs E; Hummel, Yoran M; Pozzoli, Alberto; Alfieri, Ottavio R; Rienstra, Michiel; Blaauw,
Yuri; Van Gelder, Isabelle C; Mariani, Massimo A
Abstract: Objective Thoracoscopic surgical pulmonary vein isolation (sPVI) has been added to the treat-
ment of atrial fibrillation (AF), showing excellent efficacy outcomes. However, data on right ventricular
(RV) function following sPVI has never been studied. Our aim was to investigate RV function following
sPVI and compare it to patients who underwent endocardial cryoballoon PVI. Methods 25 patients un-
derwent sPVI and were pair-matched according to age, sex, and AF type with 21 patients who underwent
cryoballoon PVI. RV function was measured using tricuspid annular plane systolic excursion (TAPSE)
and RV strain with 2D speckle tracking. Echocardiography was performed at baseline and at median
6-month follow-up. Results Age was 54 ± 9 years and 84% were male; AF was paroxysmal in 92%. In
the sPVI group, TAPSE was reduced with 31% at follow-up echocardiography ( < 0.001) and RV strain
showed a 25% reduction compared to baseline ( = 0.018). In the control group, TAPSE and RV strain
did not change significantly (-3% and +13%, = 0.410 and = 0.148). Change in TAPSE and RV strain
was significantly different between groups ( ￿ 0.001 and = 0.005). Conclusions This study shows that RV
function is significantly decreased following sPVI. This effect was not observed in the cryoballoon PVI
control group.
DOI: https://doi.org/10.1155/2018/7392435
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-165041
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
De Maat, Gijs E; Hummel, Yoran M; Pozzoli, Alberto; Alfieri, Ottavio R; Rienstra, Michiel; Blaauw,
Yuri; Van Gelder, Isabelle C; Mariani, Massimo A (2018). Impact of Thoracoscopic Pulmonary Vein
Isolation on Right Ventricular Function: A Pilot Study. BioMed Research International, 2018:7392435.
DOI: https://doi.org/10.1155/2018/7392435
Research Article
Impact of Thoracoscopic Pulmonary Vein Isolation on
Right Ventricular Function: A Pilot Study
Gijs E. De Maat ,1 YoranM. Hummel,2 Alberto Pozzoli,3 Ottavio R. Alfieri,3
Michiel Rienstra,2 Yuri Blaauw,2 Isabelle C. Van Gelder,2 andMassimo A. Mariani1
1Department of Cardiothoracic Surgery and Cardiology, University Medical Center Groningen, University of Groningen,
P.O. Box 30.001, 9700 RB Groningen, Netherlands
2Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
3Heart Surgery Unit, San Raffaele University Hospital, Milan, Italy
Correspondence should be addressed to Gijs E. De Maat; g.e.de.maat@umcg.nl
Received 30 July 2017; Revised 9 January 2018; Accepted 22 January 2018; Published 20 February 2018
Academic Editor: Christof Kolb
Copyright © 2018 Gijs E. DeMaat et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective. Thoracoscopic surgical pulmonary vein isolation (sPVI) has been added to the treatment of atrial fibrillation (AF),
showing excellent efficacy outcomes. However, data on right ventricular (RV) function following sPVI has never been studied.
Our aim was to investigate RV function following sPVI and compare it to patients who underwent endocardial cryoballoon PVI.
Methods. 25 patients underwent sPVI and were pair-matched according to age, sex, and AF type with 21 patients who underwent
cryoballoon PVI. RV function was measured using tricuspid annular plane systolic excursion (TAPSE) and RV strain with 2D
speckle tracking. Echocardiography was performed at baseline and at median 6-month follow-up. Results. Age was 54 ± 9 years
and 84% were male; AF was paroxysmal in 92%. In the sPVI group, TAPSE was reduced with 31% at follow-up echocardiography
(𝑝 < 0.001) and RV strain showed a 25% reduction compared to baseline (𝑝 = 0.018). In the control group, TAPSE and RV strain
did not change significantly (−3% and +13%, 𝑝 = 0.410 and 𝑝 = 0.148). Change in TAPSE and RV strain was significantly different
between groups (𝑝 ≤ 0.001 and 𝑝 = 0.005). Conclusions. This study shows that RV function is significantly decreased following
sPVI. This effect was not observed in the cryoballoon PVI control group.
1. Introduction
In the recent years, thoracoscopic surgical pulmonary vein
isolation (sPVI) has been added to the treatment of atrial
fibrillation (AF). This technique has been shown to be safe
and numerous studies have shown excellent efficacy outcome
in paroxysmal and short-standing persistent AF due to high
transmurality yielded epicardially by bipolar radiofrequency
devices [1, 2]. However, right ventricular (RV) function
following sPVI has not been investigated. The occurrence
of RV dysfunction is not easily predictable and is often
unexpected. However, RV function is a major determinant
of clinical outcomes following cardiac surgery [3]. With the
development of speckle tracking echocardiography, assess-
ment of the RV has become more accessible and reliable for
routine clinical practice [4]. The aim of this study was to
investigate the right ventricular (RV) function in patients
who underwent sPVI and compare it to cryoballoon PVI
outcomes.
2. Materials and Methods
We studied a series of patients who underwent sPVI as a first
PVI procedure during the period of 2009–2011 in our uni-
versity medical center. Inclusion criteria were highly symp-
tomatic paroxysmal or early persistent AF, without concomi-
tant cardiac structural disease, refractory to class I and/or
class III antiarrhythmic drugs [2]. Exclusion criteria for
surgical PVI were left atrial size > 55mm (parasternal view),
prior transcatheter PVI, prior heart or lung surgery, signifi-
cant coronary disease or previous myocardial infarction, left
ventricle hypertrophy > 12mm, previous hospitalization for
heart failure, left ventricular dysfunction (ejection fraction
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Table 1: Baseline characteristics and echocardiography outcomes.
Baseline patient characteristics
Parameter sPVI (𝑛 = 25) CRYO (𝑛 = 21) 𝑝 value
Age (years) 54 ± 9 58 ± 7 0.089
Male (𝑛, %) 21 (84%) 15 (71%) 0.303
AF history, years [range] 3 [1–14] 4 [1–15] 0.178
Paroxysmal AF (𝑛, %) 23 (92%) 17 (81%) 0.268
Short-standing persistent AF (𝑛, %) 2 (8%) 4 (19%)
BMI (kg/m2) 27.1 ± 2.9 28.2 ± 3.3 0.251
Systolic BP (mmHg) 132 ± 17 137 ± 16 0.383
Diastolic BP (mmHg) 79 ± 9 83 ± 10 0.234
AF: atrial fibrillation; BMI: body mass index; BP: blood pressure; sPVI: surgical pulmonary vein isolation; TAPSE: tricuspid annular plane systolic excursion.
< 50%), moderate or severe mitral or aortic valve disease,
or lung disease (prior tuberculosis or chronic obstructive
pulmonary disease, GOLD classes III-IV). The control group
consisted of patients with the same indication who under-
went cryoballoon PVI in the same period, also as first invasive
procedure. Patients who underwent sPVI were pair-matched
retrospectively according to age, sex, and AF type with
patients who underwent cryoballoon PVI. All sPVI patients
were treated using the video-assisted bilateral thoracoscopy.
To isolate the pulmonary veins, a bipolar radiofrequency
clamp (Isolator, AtriCure, Cincinnati, Ohio, USA) was used
to create linear, thermal lesions. Following the ablation, exit
block was confirmed, no additional linear ablation lines were
applied, and the left atrial appendage was not excluded [1, 2].
The lateral incision of the pericardium was not routinely
closed after completion of the lesion set. The control group
consisted of patients who underwent endocardial PVI using
the second-generation cryoballoon (Arctic Front Advance,
Medtronic CryoCath LP, Pointe-Claire, Canada). Follow-
ing ablation, antiarrhythmic drugs were continued during
the first three months. Patients underwent a standardized
transthoracic echocardiogrampreoperatively and at 6-month
(range: 3–12) follow-up. Offline analyses were performed
by an expert sonographer (Yoran M. Hummel) who was
blinded with respect to treatment type. All measurements
were performed using EchoPACBT12, following the 2015 rec-
ommendations of the American Society of Echocardiography
[5]. RV function was measured using tricuspid annular plane
systolic excursion (TAPSE-M-mode) and RV longitudinal
deformation (strain) with 2D speckle tracking; in an apical
four-chamber view, the edge of the RV endocardium was
manually traced, after which the software automatically gen-
erated tracings.The basal, middle, and apical segments of the
RV were traced. In the analysis, a mean strain of these three
segments was calculated. To reliably measure RV function,
patients with AF or atrial flutter during echocardiography
were excluded from the analysis.
2.1. Statistics. Baseline descriptive statistics are presented as
mean ± standard deviation or median (range) for continu-
ous variables, as appropriate, and counts with percentages
for categorical variables. Differences between groups, in
terms of patient characteristics at baseline and different
follow-up moments, were evaluated by Student’s t-test or
Mann–Whitney U test, depending on normality of the data.
Differences within subgroupswere evaluated using the paired
t-test. Chi-square or Fisher’s exact test was used for compar-
ison of categorical variables. The statistical software package
IBM SPSS Statistics v.22 was used.
3. Results
The sPVI group consisted of 25 patients, mean age was
54 ± 9 years, and 84% were male. AF was paroxysmal in
92% and short term persistent in 8%. The control group
consisted of 21 patients with similar characteristics who
underwent cryoballoon PVI in the same center and period.
Baseline patient characteristics did not differ significantly
between groups (Table 1). There was no concomitant struc-
tural coronary, heart, or valve disease present at baseline.
At baseline, echocardiography parameters were comparable
between groups except for RA length, which was larger in
the sPVI group (57.8 ± 6.2 versus 52.8 ± 5.1, 𝑝 = 0.005), but
RA width did not differ between groups (43,7 ± 5,9 versus
41,6 ± 5,1, 𝑝 = 0.212). At baseline echocardiography, TAPSE
was higher in the sPVI group compared to the cryoballoon
group (26,6 ± 4,0 versus 23,9 ± 3,7, 𝑝 = 0.025; Table 2).
In the sPVI group, RV function measured by TAPSE was
significantly reduced with a mean of −8.3mm (−31%) at
median 6-month follow-up echocardiography (𝑝 < 0.001)
(Figure 1(a)). Furthermore, the average RV strain showed a
mean change of −5.6 percentage points (−25%) compared
to baseline echocardiography (𝑝 = 0.018) (Figure 1(b)). In
the control group, the TAPSE was reduced with a mean of
−0.8mm (−3%) and RV strain increased with 2.7 percent
points (+13%); this was not significant (𝑝 = 0.410 and
𝑝 = 0.148, resp.). When the change from baseline to
follow-up (delta) measurement in TAPSE and RV strain was
compared between the two groups, this showed a significant
difference (mean TAPSE −8.3mm versus −0.8mm, 𝑝 ≤
0.001, andmean RV strain −5.6 percentage points versus +2.7
percentage points, 𝑝 = 0.005).
3.1. Procedural Outcomes. In all sPVI patients, the procedure
was completedwith proven acute exit block.Mean procedural
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Figure 1
time was 160 ± 60 minutes. Mean hospitalization was 7
± 2 days. There was no 30-day or 1-year mortality. At 12-
month follow-up, 88% of sPVI patients were free from atrial
arrhythmia and antiarrhythmic drugs. In the cryoballoon
group, all patients underwent successful PVI with proven
entry and exit block. Mean procedural time was 100 ± 20
minutes. Mean hospitalization was 3 ± 1 days. There was no
30-day or 1-year mortality. At 12-month follow-up, 67% of
patients were free from atrial arrhythmia and antiarrhythmic
drugs.
4. Discussion
This study shows that RV function is significantly decreased
following sPVI during the first year. This effect was not
observed in our control group, a similar patient popula-
tion who underwent cryoballoon PVI. Both study groups
underwent echocardiographic analysis preoperatively and at
6-month follow-up; there was no significant valve disease
and atria were moderately dilated in both groups without
significant differences at baseline, except for RA length,which
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Table 2: Echocardiography outcomes.
sPVI group echocardiography CRYO group echocardiography
Parameter Baseline Follow-up 𝑝 value Baseline Follow-up 𝑝 value
LV ejection fraction (%) 60 ± 5 57 ± 5 0.062 60 ± 6 58 ± 7 0.198
LA volume (mm3) 75 ± 19 78,3 ± 23.6 0.674 79 ± 26 71.0 ± 26.0 0.209
LA volume indexed 33,7 ± 6 35,8 ± 10.2 0.430 36.3 ± 11 34.0 ± 12.5 0.414
RA length (mm) 57,8 ± 6.2∗ 57,4 ± 5.3 0.647 52.8 ± 5.1∗ 50.1 ± 5.5 0.048
RA width (mm) 43,7 ± 5.9 43,7 ± 5.1 0.835 41.6 ± 5.1 37.6 ± 5.8 0.035
RVEDD (%) 38,8 ± 5.5 39,0 ± 5.3 0.771 39.6 ± 7.9 37.4 ± 4.5 0.332
TAPSE (mm) 26,6 ± 4.0∗ 18,3 ± 3.8 <0.001 23.9 ± 3.7∗ 23.1 ± 4.5 0.410
RV strain (%) 24.4 ± 3.7 18.8 ± 4.6 0.018 21.0 ± 6.9 23.7 ± 5.2 0.148
LA: left atrial; LV: left ventricular; RA: right atrial; RVEDD: right ventricle end diastolic diameter; sPVI: surgical pulmonary vein isolation; TAPSE: tricuspid
annular plane systolic excursion. ∗Significant difference (𝑝 < 0.05) between groups at baseline.
was larger in the sPVI, but RA width did not differ between
groups. In both groups, the left atriumwasmoderately dilated
in concordance with the disease. At baseline, mean TAPSE
was significantly higher in the sPVI group compared to
the CRYO group. However, at follow-up, this was signif-
icantly lower. This effect was objectified by means of RV
strain.
Decreased RV function following sPVI has not been
described previously. On the other hand, in patients who
underwent open-chest CABG (both on and off pump), a
reduced RV function has been already documented [6].
Remarkably, a study comparing conventional surgical aortic
valve replacement (AVR) to transcatheter AVR demonstrated
a similar reduction of RV strain at follow-up in patients
who underwent surgery [7]. Although the present analysis
does not allow definite conclusions regarding the exact
underlying mechanism, the reduction of RV function might
be attributable to two factors. First, due to the lateral opening
of the pericardium, the mechanical support (restraint) is
reduced. The right atrium and right ventricle have relatively
limited intrinsic stiffness, compared to the left heart side,
and are therefore more dependent on pericardial support
[8]. Second, the opening of the pericardium causes an
inflammatory reaction, which leads to the formation of adhe-
sions between the pericardium and the epicardium. These
adhesions can reduce compliance, especially of thin-walled
chambers (RA and RV), and thereby impair ventricular
filling. Of course, also a combination of both factors could
contribute to a reducedRV function following sPVI.Whether
decrease in RV function is permanent is associated with
symptoms or even heart failure needs to be determined in
future studies. An appropriate understanding of pericardial
constraint is required. The observational nature of our study
and limited number of patients do not allow definitive
conclusions.
In conclusion, this study shows that RV function is
significantly decreased following sPVI during the first year.
This effect was not observed in a similar patient population
that underwent cryoballoon PVI. In accordance with the
findings of this study, our operative protocol has changed.
The right pericardial incision is now routinely closed with
approximating endosutures.
Conflicts of Interest
The authors report no conflicts of interest.
Acknowledgments
The authors thank Dr. Bastiaan Geelhoed for his statistical
advice and contribution to the figures.
References
[1] A. Yilmaz, B. P. van Putte, and W. J. van Boven, “Completely
thoracoscopic bilateral pulmonary vein isolation and left atrial
appendage exclusion for atrial fibrillation,” The Journal of
Thoracic and Cardiovascular Surgery, vol. 136, no. 2, pp. 521-522,
2008.
[2] G. E. de Maat, A. Pozzoli, M. F. Scholten et al., “Surgical
minimally invasive pulmonary vein isolation for lone atrial fib-
rillation: midterm results of a multicenter study,” Innovations :
technology and techniques in cardiothoracic and vascular surgery,
vol. 8, no. 6, pp. 410–415, 2013.
[3] F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt, “Right
ventricular function in cardiovascular disease, part II: patho-
physiology, clinical importance, and management of right
ventricular failure,” Circulation, vol. 117, no. 13, pp. 1717–1731,
2008.
[4] L. L. Mertens and M. K. Friedberg, “Imaging the right
ventricleg-current state of the art,” Nature Reviews Cardiology,
vol. 7, no. 10, pp. 551–563, 2010.
[5] R. M. Lang, L. P. Badano, and V. Mor-Avi, “Recommendations
for cardiac chamber quantification by echocardiography in
adults: an update from the American Society of Echocardiogra-
phy and the European Association of Cardiovascular Imaging,”
Journal of the American Society of Echocardiography, vol. 28, no.
1, pp. 1.e14–39.e14, 2015.
[6] A. Raina, A. Vaidya, Z. M. Gertz, Susan Chambers, and P.
R. Forfia, “Marked changes in right ventricular contractile
pattern after cardiothoracic surgery: Implications for post-
surgical assessment of right ventricular function,” The Journal
of Heart and Lung Transplantation, vol. 32, no. 8, pp. 777–783,
2013.
BioMed Research International 5
[7] A. Kempny, G.-P. Diller, G. Kaleschke et al., “Impact of
transcatheter aortic valve implantation or surgical aortic valve
replacement on right ventricular function,” Heart, vol. 98, no.
17, pp. 1299–1304, 2012.
[8] H. S. Maniar, S. M. Prasad, S. L. Gaynor, C. M. Chu, P.
Steendijk, and M. R. Moon, “Impact of pericardial restraint on
right atrial mechanics during acute right ventricular pressure
load,” American Journal of Physiology-Heart and Circulatory
Physiology, vol. 284, no. 1, pp. H350–H357, 2003.
Stem Cells 
International
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
MEDIATORS
INFLAMMATION
of
Endocrinology
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Disease Markers
Hindawi
www.hindawi.com Volume 2018
BioMed 
Research International
Oncology
Journal of
Hindawi
www.hindawi.com Volume 2013
Hindawi
www.hindawi.com Volume 2018
Oxidative Medicine and 
Cellular Longevity
Hindawi
www.hindawi.com Volume 2018
PPAR Research
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013www.hindawi.com
The Scientific 
World Journal
8
Immunology Research
Hindawi
www.hindawi.com Volume 2018
Journal of
Obesity
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
 Computational and  
Mathematical Methods 
in Medicine
Hindawi
www.hindawi.com Volume 2018
Behavioural 
Neurology
Ophthalmology
Journal of
Hindawi
www.hindawi.com Volume 2018
Diabetes Research
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Research and Treatment
AIDS
Hindawi
www.hindawi.com Volume 2018
Gastroenterology 
Research and Practice
Hindawi
www.hindawi.com Volume 2018
Parkinson’s 
Disease
Evidence-Based 
Complementary and
Alternative Medicine
Volume 2018
Hindawi
www.hindawi.com
Submit your manuscripts at
www.hindawi.com
